Surge in GLP-1 overdoses linked to easy telehealth and unregulated meds

GLP-1 diabetes/weight‑loss drugs are seeing a rise in life‑threatening overdoses as use has surged since 2021 and telehealth lowers barriers to access, sometimes bypassing in-person care. Poison‑control calls jumped from about 100 monthly in 2021 to roughly 1,000 by 2025, with patients suffering severe vomiting, dehydration, seizures, and even vomiting blood. Compounded or online‑sourced versions can have inconsistent dosing and less doctor oversight, prompting FDA warnings about unregulated products. Experts urge caution, proper dosing, and urgent care for severe symptoms, noting risks like pancreatitis and hypoglycemia, with children also at risk.